CHLOE LAVELL: Open Payments
NPI 1083239321 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 49 payments from 17 companies in 2025. Trend: 2023 $806 · 2024 $785 · 2025 $984
Food & beverage: $819Education: $165
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $155 |
| Janssen Biotech, Inc. | 6 | $149 |
| ABBVIE INC. | 9 | $147 |
| Incyte Corporation | 5 | $95 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| Galderma Laboratories, L.P. | 3 | $50 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| LEO Pharma Inc. | 2 | $38 |
| UCB, Inc. | 2 | $36 |
Products named: TREMFYA, OPZELURA, Sotyktu, RINVOQ, SKYRIZI, NEMLUVIO, Zoryve, COSENTYX.
Industry payments across PA — which companies pay providers there.
